FORM 4
[ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

BELINFANTI GREGORY 		2. Issuer Name and Ticker or Trading Symbol

ARTHROCARE CORP [ ARTC ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

C/O ARTHROCARE CORPORATION, 7000 W WILLIAM CANNON BLDG ONE 		3. Date of Earliest Transaction (MM/DD/YYYY)

5/29/2014
(Street)

AUSTIN, TX 78735
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   5/29/2014     M    17021   A   (1) 17021   I   One Equity Partners III, L.P. (See Footnote 8)  
Common Stock   5/29/2014     M    3728   A   (1) 20749   I   One Equity Partners III, L.P. (See Footnote 8)  
Common Stock   5/29/2014     M    3213   A   (1) 23962   I   One Equity Partners III, L.P. (See Footnote 8)  
Common Stock   5/29/2014     M    4312   A   (1) 28274   I   One Equity Partners III, L.P. (See Footnote 8)  
Common Stock   5/29/2014     M    3300   A   (1) 31574   I   One Equity Partners III, L.P. (See Footnote 8)  
Common Stock   5/29/2014     D    31574   D   (2) 0   I   One Equity Partners III, L.P. (See Footnote 8)  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units     (1) 5/29/2014     M         17021      (3)   (3) Common Stock   17021   $0   14553   I   (8) One Equity Partners III, L.P. (See Footnote 8)  
Restricted Stock Units     (1) 5/29/2014     M         3728      (4)   (4) Common Stock   3728   $0   10825   I   (8) One Equity Partners III, L.P. (See Footnote 8)  
Restricted Stock Units     (1) 5/29/2014     M         3213      (5)   (5) Common Stock   3213   $0   7612   I   (8) One Equity Partners III, L.P. (See Footnote 8)  
Restricted Stock Units     (1) 5/29/2014     M         4312      (6)   (6) Common Stock   4312   $0   3300   I   (8) One Equity Partners III, L.P. (See Footnote 8)  
Restricted Stock Units     (1) 5/29/2014     M         3300      (7)   (7) Common Stock   3300   $0   0   I   (8) One Equity Partners III, L.P. (See Footnote 8)  

Explanation of Responses:
( 1)  Each restricted stock unit converts into one share of ArthoCare Corporation (the "Issuer") common stock.
( 2)  Disposed of pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of February 2, 2014, by and among the Issuer, Smith & Nephew, Inc., a Delaware corporation ("Smith & Nephew"), Rosebud Acquisition Corporation, a Delaware corporation and wholly owned subsidiary of Smith & Nephew, and Smith & Nephew plc, an English public limited company in exchange for $48.25 per share in cash on the effective date of the merger.
( 3)  On December 16, 2009, the reporting person was granted 17,021 restricted stock units, with an initial 20.00% of such award vesting on September 1, 2010 and 20.00% of such award vesting on each of the successive four anniversaries of the initial vesting date. The restricted stock units became fully vested pursuant to their terms upon a change of control as occurred on May 29, 2014, pursuant to the Merger Agreement.
( 4)  On May 12, 2010, the reporting person was granted 3,728 restricted stock units, vesting in three equal installments with an initial 33.33% of such award vesting on March 12, 2011 and 33.33% of such award vesting on each of the successive two anniversaries of the initial vesting date.
( 5)  On May 12, 2011, the reporting person was granted 3,213 restricted stock units, vesting in three equal installments with an initial 33.33% of such award vesting on May 12, 2012 and 33.33% of such award vesting on each of the successive two anniversaries of the initial vesting date. The restricted stock units became fully vested pursuant to their terms upon a change of control as occurred on May 29, 2014, pursuant to the Merger Agreement.
( 6)  On May 24, 2012, the reporting person was granted 4,312 restricted stock units, vesting in three equal installments with an initial 33.33% of such award vesting on May 24, 2013 and 33.33% of such award vesting on each of the successive two anniversaries of the initial vesting date. The restricted stock units became fully vested pursuant to their terms upon a change of control as occurred on May 29, 2014, pursuant to the Merger Agreement.
( 7)  On May 22, 2013, the reporting person was granted 3,300 restricted stock units, vesting in three equal installments with an initial 33.33% of such award vesting on May 22, 2014 and 33.33% of such award vesting on each of the successive two anniversaries of the initial vesting date. The restricted stock units became fully vested pursuant to their terms upon a change of control as occurred on May 29, 2014, pursuant to the Merger Agreement.
( 8)  The Reporting Person is an officer of OEP AC Holdings, LLC, a Delaware limited liability company ("OEP"). The managing member of OEP is One Equity Partners III, L.P., a Cayman Islands limited partnership ("OEP III"), of which the sole general partner is OEP General Partner III, L.P., a Cayman Islands limited partnership ("OEP GP III"), of which the sole general partner is OEP Parent, LLC, a Delaware limited liability company ("OEP Parent"), of which the sole member is OEP Holding Corporation, a Delaware corporation ("OEP Holding"), of which the sole stockholder is JPMorgan Capital Corporation, a Delaware corporation ("JPM CC"), of which the sole stockholder is Banc One Financial LLC, a Delaware limited liability company ("BOF LLC"), of which the sole member is JPMorgan Chase & Co., a Delaware corporation. The Reporting Person holds these restricted stock units for the benefit of OEP III.

Remarks:
The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
BELINFANTI GREGORY
C/O ARTHROCARE CORPORATION
7000 W WILLIAM CANNON BLDG ONE
AUSTIN, TX 78735 		X



Signatures
/s/ Gregory A. Belinfanti 6/3/2014
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Arthrocare Corp. (MM) (NASDAQ:ARTC)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Arthrocare Corp. (MM) Charts.
Arthrocare Corp. (MM) (NASDAQ:ARTC)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Arthrocare Corp. (MM) Charts.